Shenbai Shuxin capsule of Kaiyuan pharmaceutical, a subsidiary of Zhendong pharmaceutical, is about to obtain the production approval
-
Last Update: 2014-08-01
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to the information released by the State Food and Drug Administration on August 1, the evaluation status of shenbaishuxin capsule, a traditional Chinese medicine variety of Kaiyuan pharmaceutical, a subsidiary of Zhendong pharmaceutical, changed to "approved - to be certified" On Friday, the company's relevant person in charge said that the drug's previous review process had passed and was waiting for the certificate to be issued The market prospect of the drug is broad, the company's production conditions have been met, and production will be arranged as soon as possible According to the public information, Shenyang Dongling Pharmaceutical Co., Ltd obtained the approval of Shenbai Shuxin capsule in March 2011, and then the approval was resold to Kaiyuan pharmaceutical, which was disclosed in the first quarter of 2011 by Zhendong pharmaceutical According to the above person in charge, the company has bought out this approval, and Shenbai Shuxin capsule has become the exclusive product of the company The main efficacy of the drug is to promote blood circulation and remove blood stasis, which has therapeutic effect on palpitation and upset Because the application field is cardio cerebral vascular, the market prospect is very broad.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
